GOVXW Projected Dividend Yield
Wt Exp 01/01/2025/GeoVax Labs Inc ( NASDAQ : GOVXW )GeoVax Labs is a clinical-stage biotechnology company developing immunotherapies and vaccines against infectious diseases and solid tumor cancers using vector vaccine platforms. Co.'s product pipeline includes human clinical trials in COVID-19 vaccine and a theraphy against head and neck cancer. Additional research and development programs include preventive vaccines against Monkeypox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa) and Zika virus, as well as immunotherapies for multiple solid tumors. Co.'s cancer therapy programs are Gedeptin® and MUC1-based Immunotherapy. 20 YEAR PERFORMANCE RESULTS |
GOVXW Dividend History Detail GOVXW Dividend News GOVXW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |